RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Improvements in symptoms, impact of treatment, and satisfaction with treatment among patients with relapsed or refractory b-cell non-Hodgkin Lymphoma treated with subcutaneous epcoritamab
Kosa, K., Mutebi, A., Wang, A., Blaedel, J., Sacchi, M., & Martin, S. (2023). Improvements in symptoms, impact of treatment, and satisfaction with treatment among patients with relapsed or refractory b-cell non-Hodgkin Lymphoma treated with subcutaneous epcoritamab. Value in Health, 26(6), S315. https://doi.org/10.1016/j.jval.2023.03.1800